drugset / Trial / NCT05324423
To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout
NaSingle-groupOpen-labelTreatment
Summary
A single-center, open-access study to evaluate drug interactions between XNW3009, febuxostat, and colchicine in patients with gout
Timeline
- Start
- 2021-10-18
- Primary completion
- 2022-08-01
- Completion
- 2022-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colchicine | Small molecule | 0.5 mg | Oral |
| Subject | Febuxostat | Small molecule | 40 mg | Oral |
| Subject | XNW3009 | Small molecule | 0.5 mg | Oral |